This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms.
Presenter: Aparna Krishnan
Contributors: James Mackay, President & CEO of Aristea Therapeutics
Producer: Operations team
About Aristea Therapeutics, a San Diego-based clinical-stage immunology-focused drug development company developing novel therapies for serious, rare inflammatory diseases.
Weekly Roundup: February 28, 2019
Weekly Roundup: February 22, 2019
Weekly Roundup: February 15, 2019
Weekly Roundup: February 1, 2019
Weekly Roundup: January 25, 2019
Weekly Roundup: January 18, 2019
Weekly Roundup: January 11, 2019
Weekly Roundup: December 14, 2018
Weekly Roundup: December 7, 2018
Weekly Roundup: November 30, 2018
Weekly Roundup: November 23, 2018
Weekly Roundup: November 15, 2018
Weekly Roundup: November 9, 2018
Weekly Roundup: November 2, 2018
Weekly Roundup: October 25, 2018
Weekly Roundup: October 18, 2018
Weekly Roundup: October 11, 2018
Weekly Roundup: Oct 5, 2018
Weekly Roundup: Sep 27, 2018
Weekly Roundup: September 20, 2018
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain